Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Arlene Chan
Breast Cancer Research Centre WA
Principal Investigator - Cheol Kyung Sin
Ulsan University Hospital
Principal Investigator - Do-Youn Oh
Seoul National University Hospital
Principal Investigator - Ganessan Kichenadasse
Southern Oncology Clinical Research Unit
Principal Investigator - Hae Seong Park
Dana-Farber Cancer Institute
Principal Investigator - Hongjae Chon
CHA Bundang Medical Center
Principal Investigator - Hongsik Kim
Chungbuk National University Hospital
Principal Investigator - Hyejin Choi
Severance Hospital
Principal Investigator - Hyung Soon Park
Catholic University of Korea St. Vincent's Hospital
Principal Investigator - Jennifer Man
Blacktown Hospital
Principal Investigator - Ji Hong Bae
Gachon Gil University Medical Center
Principal Investigator - Joon Oh Park
Samsung Medical Center
Principal Investigator - Ju Won Kim
Korea University Anam Hospital
Principal Investigator - Jung Hun Kang
Gyeongsang National University Hospital
Principal Investigator - Kyu-pyo Kim
Asan Medical Center
Principal Investigator - Myung Ah Lee
The Catholic University of Korea, St. Mary's hospital
Principal Investigator - Niall Tebbutt
Austin Health
Principal Investigator - Seok Yun Kang
Ajou University School of Medicine
Principal Investigator - Thatcher Heumman
Vanderbilt-Ingram Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southern Oncology Clinical Research Unit
Adelaide, Australia
Terminated - Austin Health
Melbourne, Australia
Withdrawn - Breast Cancer Research Centre - Wa
Perth, Australia
Withdrawn - Blacktown Hospital
Sydney, Australia
Recruiting
- Cha Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea
Recruiting - Ajou University Hospital
Suwon, Gyeonggi-do, South Korea
Recruiting - Catholic University of Korea St. Vincent'S Hospital
Suwon, Gyeonggi-do, South Korea
Recruiting - Gyeongsang National University Hospital
Jinju, Gyeongsangnam-do, South Korea
Recruiting - Chungbuk National University Hospital
Cheongju-si, North Chungcheong, South Korea
Recruiting - Gachon Gil University Medical Center
Incheon, South Korea
Recruiting - Asan Medical Center
Seoul, South Korea
Recruiting - Korea University Anam Hospital
Seoul, South Korea
Recruiting - Samsung Medical Center
Seoul, South Korea
Recruiting - Seoul National University Hospital
Seoul, South Korea
Recruiting - Severance Hospital, Yonsei University Health System
Seoul, South Korea
Recruiting - the Catholic University of Korea, St. Mary'S Hospital
Seoul, South Korea
Recruiting - Ulsan University Hospital
Ulsan, South Korea
Recruiting
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting - Vanderbilt Ingram Cancer Center
Nashville, Tennessee, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Aug 2022
- Primary completion
- 31 Mar 2028
- Completion
- 30 Apr 2028
- Last update posted
- 16 Jul 2026
- Registered enrollment
- 147
- Registry id
- NCT05523947
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.